0000920465-19-000049.txt : 20190304
0000920465-19-000049.hdr.sgml : 20190304
20190304173314
ACCESSION NUMBER: 0000920465-19-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 19655403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_155173878033378.xml
FORM 4
X0306
4
2019-02-28
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
1
1
0
0
President, CEO & Secretary
Common Stock
2019-02-28
4
A
0
261
4.85
A
1263604
D
Common Stock
22000
I
By children
Stock Option (Right to Buy)
5.7
2019-02-28
4
A
0
261
0
A
2029-02-28
Common Stock
261.0
261
D
These shares were acquired on 02/28/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
/s/ Ryan Murr, as attorney-in-fact for George Tidmarsh
2019-03-04